Assignee
CANCER RES TECH LTD
GB·14 granted patents·4 pending applications·74 citations·filing 2013–2017
Top patents by PatentIndex Score
18 records- 0192US9765059B25-(Pyridin-2-yl-amino)-pyrazine-2-carbonitrile compounds and their therapeutic useCANCER RES TECH LTD·Filed 2016·Granted Sep 19, 2017·6 cites·20 claims
- 0292US9409907B2Inhibitor compoundsCANCER RES TECH LTD·Filed 2013·Granted Aug 9, 2016·14 cites·2 claims
- 0391US9403797B25-(pyridin-2-yl-amino)-pyrazine-2-carbonitrile compounds and their therapeutic useCANCER RES TECH LTD·Filed 2015·Granted Aug 2, 2016·6 cites·38 claims
- 0487US9604994B2Thienopyrimidine inhibitors of atypical protein kinase CCANCER RES TECH LTD·Filed 2014·Granted Mar 28, 2017·12 cites·26 claims
- 0586US9701664B2Fused 1,4-dihydrodioxin derivatives as inhibitors of heat shock transcription factor 1CANCER RES TECH LTD·Filed 2014·Granted Jul 11, 2017·8 cites·2 claims
- 0685US9725447B21-(5-tert-butyl-2-aryl-pyrazol-3-yl)-3-[2-fluoro-4-[(3-oxo-4H-pyrido[2,3-b]pyrazin-8-yl)oxy]phenyl]urea derivatives as RAF inhibitors for the treatment of cancerCANCER RES TECH LTD·Filed 2014·Granted Aug 8, 2017·8 cites·45 claims
- 0785US9439893B21-(5-tert-butyl-2-phenyl-2H-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-B]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapyCANCER RES TECH LTD·Filed 2015·Granted Sep 13, 2016·4 cites·29 claims
- 0881US9708317B2Process for the preparation of 8-(4-aminophenoxy)-4H-pyrido[2,3-B]pyrazin-3-one derivativesCANCER RES TECH LTD·Filed 2014·Granted Jul 18, 2017·2 cites·83 claims
- 0981US9663503B25-[[4-[[morpholin-2-yl]methylamino]-5-(trifluoromethyl)-2-pyridyl]amino]pyrazine-2-carbonitrile and therapeutic uses thereofCANCER RES TECH LTD·Filed 2013·Granted May 30, 2017·5 cites·19 claims
- 1071US9650416B2αvβ6 peptide ligands and their usesCANCER RES TECH LTD·Filed 2014·Granted May 16, 2017·1 cites·15 claims
- 1170US9683032B2Anti-S100A4 antibody molecules and their usesCANCER RES TECH LTD·Filed 2013·Granted Jun 20, 2017·4 cites·26 claims
- 1265US9447092B2Pharmaceutically active compoundsCANCER RES TECH LTD·Filed 2013·Granted Sep 20, 2016·1 cites·9 claims
- 1363US9725518B2Antibodies that bind to Jagged 1CANCER RES TECH LTD·Filed 2014·Granted Aug 8, 2017·3 cites·17 claims
- 1454US9771362B2[1,2,4]triazolo[1,5-a]pyridine and [1,2,4]triazolo[1,5-c]pyrimidine compounds and their useCANCER RES TECH LTD·Filed 2016·Granted Sep 26, 2017·0 cites·24 claims
- 1553US2017096667A1INHIBITING GENE EXPRESSION WITH dsRNACANCER RES TECH LTD·Filed 2016·Application pending·0 cites
- 1652US2016355478A1Therapeutic agentsCANCER RES TECH LTD·Filed 2016·Application pending·0 cites
- 1748US2017121418A1Cd55-interaction partners and the uses thereofCANCER RES TECH LTD·Filed 2017·Application pending·0 cites
- 1841US2016223442A1Biological fluid filtration assemblyCANCER RES TECH LTD·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CANCER RES TECH LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →